Amedeo Smart

Free Medical Literature Service


 

Amedeo

HIV Infection

  Free Subscription

16.08.2021

2 AIDS
3 AIDS Res Hum Retroviruses
1 Am J Hematol
1 Antimicrob Agents Chemother
5 Clin Infect Dis
2 HIV Med
3 J Acquir Immune Defic Syndr
1 J Clin Invest
1 J Med Virol
1 J Virol
1 JAMA
2 N Engl J Med
1 Nature
1 Pediatr Infect Dis J
13 PLoS One
2 PLoS Pathog
1 Vaccine



    AIDS

  1. LLOYD AR, Savage R, Eaton E
    Opioid use disorder: a neglected human immunodeficiency virus risk in American adolescents.
    AIDS. 2021 Aug 13. pii: 00002030-900000000-96331.
    >> Share

  2. PREMEAUX TA, Moser CB, McKhann A, Hoenigl M, et al
    Plasma galectin-9 as a predictor of adverse non-AIDS events in persons with chronic HIV during suppressive antiretroviral therapy.
    AIDS. 2021 Aug 6. pii: 00002030-900000000-96334.
    >> Share


    AIDS Res Hum Retroviruses

  3. MCGOWAN IM, Chawki S, Hendrix CW, Anton PA, et al
    A Randomized, Open Label, Crossover Phase 1 Safety and Pharmacokinetic Study of Oral Maraviroc and Maraviroc 1% Gel (the CHARM-03 Study).
    AIDS Res Hum Retroviruses. 2021 Aug 12. doi: 10.1089/AID.2021.0096.
    >> Share

  4. DOOLAN B, Yeon J, Baker D, Whitfeld M, et al
    Dupilumab therapy for atopic dermatitis in people living with HIV.
    AIDS Res Hum Retroviruses. 2021 Aug 12. doi: 10.1089/AID.2021.0113.
    >> Share

  5. SARKAR S, Haberlen S, Post W, Kelesidis T, et al
    Plasma Lymphocyte Activation Gene 3 and Subclinical Coronary Artery Disease in the Multicenter AIDS Cohort Study.
    AIDS Res Hum Retroviruses. 2021 Aug 12. doi: 10.1089/AID.2021.0035.
    >> Share


    Am J Hematol

  6. PARSONS K, Ayalew Y, Jackson C, Leach M, et al
    Atypical lymphocytosis due to CD8-positive T-cell expansion in unsuspected HIV infection.
    Am J Hematol. 2021 Aug 11. doi: 10.1002/ajh.26318.
    >> Share


    Antimicrob Agents Chemother

  7. NGWALERO P, Brust JCM, van Beek SW, Wasserman S, et al
    Relationship between plasma and intracellular concentrations of bedaquiline and its M2 metabolite in South African patients with rifampin-resistant TB.
    Antimicrob Agents Chemother. 2021 Aug 9:AAC0239920. doi: 10.1128/AAC.02399.
    >> Share


    Clin Infect Dis

  8. HUSTON CD
    The Clofazimine for Treatment of Cryptosporidiosis in HIV-Infected Adults (CRYPTOFAZ) and Lessons Learned for Anticryptosporidial Drug Development.
    Clin Infect Dis. 2021;73:192-194.
    >> Share

  9. ROCKSTROH JK
    Non-invasive markers for monitoring fibrosis regression after HCV-cure: what do they promise?
    Clin Infect Dis. 2020 Jun 5. pii: 5854050. doi: 10.1093.
    >> Share

  10. CABY F, Guiguet M, Weiss L, Winston A, et al
    CD4/CD8 Ratio and the Risk of Kaposi Sarcoma or Non-Hodgkin Lymphoma in the Context of Efficiently Treated Human Immunodeficiency Virus (HIV) Infection: A Collaborative Analysis of 20 European Cohort Studies.
    Clin Infect Dis. 2021;73:50-59.
    >> Share

  11. JACOBS JL, Bain W, Naqvi A, Staines B, et al
    SARS-CoV-2 Viremia is Associated with COVID-19 Severity and Predicts Clinical Outcomes.
    Clin Infect Dis. 2021 Aug 10. pii: 6347519. doi: 10.1093.
    >> Share

  12. CHANG AY, Rwebembera J, Bendavid E, Okello E, et al
    Clinical Outcomes, Echocardiographic Findings, and Care Quality Metrics for People Living with HIV and Rheumatic Heart Disease in Uganda.
    Clin Infect Dis. 2021 Aug 12. pii: 6348878. doi: 10.1093.
    >> Share


    HIV Med

  13. PINCUS KJ, Blackman AL, Suen SY, Devabhakthuni S, et al
    Statin gap in patients living with HIV: assessing dose appropriateness.
    HIV Med. 2021 Aug 8. doi: 10.1111/hiv.13150.
    >> Share

  14. FRANGE P, Blanche S, Veber F, Avettand-Fenoel V, et al
    Dolutegravir in the long term in children and adolescents: frequent virological failure but rare acquired genotypic resistance.
    HIV Med. 2021 Aug 8. doi: 10.1111/hiv.13154.
    >> Share


    J Acquir Immune Defic Syndr

  15. FRENKEL LM, Leavitt Morrison R, Fuller TL, Isabel Gouvea M, et al
    Vaginal Viral Shedding with Undetectable Plasma HIV Viral Load in Pregnant Women Receiving Two Different Antiretroviral Regimens: A Randomized Clinical Trial.
    J Acquir Immune Defic Syndr. 2021 Aug 7. pii: 00126334-900000000-95826.
    >> Share

  16. DAILEY A, Johnson AS, Hu X, Gant Z, et al
    Trends in HIV Care Outcomes Among Adults and Adolescents - 33 Jurisdictions, United States, 2014-2018.
    J Acquir Immune Defic Syndr. 2021 Aug 4. pii: 00126334-900000000-95827.
    >> Share

  17. DETTINGER JC, Pintye J, Dollah A, Awuor M, et al
    "What is this PrEP?"- Sources and accuracy of HIV Pre-Exposure Prophylaxis (PrEP) awareness among adolescent girls and young women attending family planning and maternal child health clinics in Western Kenya.
    J Acquir Immune Defic Syndr. 2021 Aug 9. pii: 00126334-900000000-95825.
    >> Share


    J Clin Invest

  18. LIU B, Zhang W, Xia B, Jing S, et al
    Broadly neutralizing antibody-derived CAR-T cells reduce viral reservoir in HIV-1-infected individuals.
    J Clin Invest. 2021 Aug 10. pii: e150211. doi: 10.1172/JCI150211.
    >> Share


    J Med Virol

  19. COUSIN E, Belicard F, Michel L, Pronier C, et al
    Severe cytomegalovirus disease with encephalitis after CAR-T cell therapy: a rare but potentially fatal complication.
    J Med Virol. 2021 Aug 9. doi: 10.1002/jmv.27257.
    >> Share


    J Virol

  20. BRETON Y, Barat C, Tremblay MJ
    The balance between p53 isoforms modulates the efficiency of HIV-1 infection in macrophages.
    J Virol. 2021 Aug 11:JVI0118821. doi: 10.1128/JVI.01188.
    >> Share


    JAMA

  21. KUEHN BM
    US Won't Meet National Goal Without Increased HIV Testing.
    JAMA. 2021;326:474.
    >> Share


    N Engl J Med

  22. ABDOOL KARIM Q
    Enhancing HIV Prevention with Injectable Preexposure Prophylaxis.
    N Engl J Med. 2021;385:652-653.
    >> Share

  23. LANDOVITZ RJ, Donnell D, Clement ME, Hanscom B, et al
    Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women.
    N Engl J Med. 2021;385:595-608.
    >> Share


    Nature

  24. KIDMAN R
    Use HIV's lessons to help children orphaned by COVID-19.
    Nature. 2021;596:185-188.
    >> Share


    Pediatr Infect Dis J

  25. JONNALAGADDA S, Auld A, Jahn A, Saito S, et al
    Opportunities for Closing the Gap in HIV Diagnosis, Treatment, and Viral Load Suppression in Children in Malawi: Results From a 2015-2016 Population-based HIV Impact Assessment Survey.
    Pediatr Infect Dis J. 2021 Aug 10. pii: 00006454-900000000-95708.
    >> Share


    PLoS One

  26. CUSHNIE A, Reintjes R, Lehtinen-Jacks S, Figueroa JP, et al
    HIV program outcomes for Jamaica before and after "Treat All": A population-based study using the national treatment services database.
    PLoS One. 2021;16:e0255781.
    >> Share

  27. HARUNA T, Somba M, Siril H, Mahiti G, et al
    Factors hindering integration of care for non-communicable diseases within HIV care services in Dar es Salaam, Tanzania: The perspectives of health workers and people living with HIV.
    PLoS One. 2021;16:e0254436.
    >> Share

  28. LULSEGED S, Belete W, Ahmed J, Gelibo T, et al
    Factors associated with unawareness of HIV-positive status in urban Ethiopia: Evidence from the Ethiopia population-based HIV impact assessment 2017-2018.
    PLoS One. 2021;16:e0255163.
    >> Share

  29. KAYS M, Woelk G, Callahan T, Katirayi L, et al
    Evaluating the effect of a community score card among pregnant and breastfeeding women living with HIV in two districts in Malawi.
    PLoS One. 2021;16:e0255788.
    >> Share

  30. LEBELONYANE R, Bachanas P, Block L, Ussery F, et al
    To achieve 95-95-95 targets we must reach men and youth: High level of knowledge of HIV status, ART coverage, and viral suppression in the Botswana Combination Prevention Project through universal test and treat approach.
    PLoS One. 2021;16:e0255227.
    >> Share

  31. AKSAK-WAS BJ, Parczewski M, Urbanska A, Hackiewicz M, et al
    Influence of HLA-B*5701 on 20 year survival rate among patients living with HIV.
    PLoS One. 2021;16:e0255834.
    >> Share

  32. MULWA S, Chimoyi L, Agbla S, Osindo J, et al
    Impact of the DREAMS interventions on educational attainment among adolescent girls and young women: Causal analysis of a prospective cohort in urban Kenya.
    PLoS One. 2021;16:e0255165.
    >> Share

  33. AYENI OA, Walaza S, Tempia S, Groome M, et al
    Mortality in children aged <5 years with severe acute respiratory illness in a high HIV-prevalence urban and rural areas of South Africa, 2009-2013.
    PLoS One. 2021;16:e0255941.
    >> Share

  34. YUNIHASTUTI E, Hariyanto R, Sulaiman AS, Harimurti K, et al
    Hepatitis C continuum of care: Experience of integrative hepatitis C treatment within a human immunodeficiency virus clinic in Indonesia.
    PLoS One. 2021;16:e0256164.
    >> Share

  35. ASSAF RD, Konda KA, Torres TS, Vega-Ramirez EH, et al
    Are men who have sex with men at higher risk for HIV in Latin America more aware of PrEP?
    PLoS One. 2021;16:e0255557.
    >> Share

  36. LE ROUX DM, Nicol MP, Vanker A, Nduru PM, et al
    Factors associated with serious outcomes of pneumonia among children in a birth cohort in South Africa.
    PLoS One. 2021;16:e0255790.
    >> Share

  37. PONCET L, Panjo H, Ringa V, Andro A, et al
    Do vulnerable groups access prevention services? Cervical cancer screening and HIV testing among homeless migrant women in the Paris metropolitan area.
    PLoS One. 2021;16:e0255900.
    >> Share

  38. DDUNGU A, Semitala FC, Castelnuovo B, Sekaggya-Wiltshire C, et al
    Chronic obstructive pulmonary disease prevalence and associated factors in an urban HIV clinic in a low income country.
    PLoS One. 2021;16:e0256121.
    >> Share


    PLoS Pathog

  39. CORLEY MJ, Sacdalan C, Pang AP, Chomchey N, et al
    Abrupt and altered cell-type specific DNA methylation profiles in blood during acute HIV infection persists despite prompt initiation of ART.
    PLoS Pathog. 2021;17:e1009785.
    >> Share

  40. ZHUKOVA A, Voznica J, Davila Felipe M, To TH, et al
    Cuban history of CRF19 recombinant subtype of HIV-1.
    PLoS Pathog. 2021;17:e1009786.
    >> Share


    Vaccine

  41. D'SOUZA MP, Palin AC, Calder T, Golding H, et al
    Mind the gap from research laboratory to clinic: Challenges and opportunities for next-generation assays in human diseases.
    Vaccine. 2021 Aug 5. pii: S0264-410X(21)00964.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016